Advanced Filters
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
noise

Found 2,822 clinical trials

N Niek Sperna Weiland, MD PhD

The Influence of Two Different CO2 Absorbers on Sevoflurane Consumption During Anaesthesia

Traditional sodalime CO2 absorbers are known to not only react with CO2 but also with sevoflurane. Therewith, a potentially harmful compound (compound A) is formed that can be nephrotoxic. In the United States, the sevoflurane manufacturer therefore recommends keeping the FGF (FGF) at >2.0 L min-1 if a sodalime CO2 …

18 years and older All Phase N/A
R Ronan ABGRAL, MD-PhD

PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy

The value of 4D body-to-whole dynamic acquisition in FDG PET / CT to differentiate progression / pseudo-progression during the first therapeutic assessment (PET1) of metastatic melanoma treated with immune checkpoint inhibitors (ICI)to predict the progression of the disease..

18 years and older All Phase N/A
H Hyoseok Na, pf

Dexmedetomidine and Blood Coagulation

Dexmedetomidine may alter whole blood coagulation. However, little is known about the dose-response relationships according to the blood concentration of dexmedetomidine. The investigators have therefore performed the present study to measure the effect of dexmedetomidine on the coagulation pathway according to the drug concentration level using a rotational thromboelastometry test.

20-65 years All Phase N/A
C Christian RIGHINI

Safety Validation of EndoSWIR Device

Head and neck cancer has an incidence of 600,000 cases per year worldwide (6th among cancers) and cause 380,000 death per year. Surgical resection is guided by the surgeon's inspection and palpation of the tumor. The prognosis of patients depends on the quality of the lesion's resection. The ENDOSWIR dispositive …

18 years and older All Phase N/A
K Kathryn Myhill

Men's Experience of Prostate Biopsy

Men aged over 18 having a first or second diagnostic prostate biopsy at the Royal Marsden NHS Foundation Trust or Epsom General Hospital may be invited to take part in one to one interview within 6 months of having the procedure done to talk about their experience

18 years and older Male Phase N/A
S Saniye Aydoğan Arslan

Turkish Version of the Brief-BESTest Scale

The aim of this study is to investigate the validity and reliability of the Turkish version of the brief-BESTest (short BESTest) scale in stroke patients.

40 years and older All Phase N/A
Q Quanli Gao, M.D

L-TIL in Patients With Malignancy Resistance to Anti-PD-1 Therapy

Safety and effectiveness of liquid tumor infiltrating lymphocytes in patients with advanced malignant tumors who have failed to anti-PD-1 therapy

18-70 years All Phase N/A
S Sophie Riedl

Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - PINNACLE

We will conduct a prospective non-interventional study including 400 early AMD patients (=600 untreated early AMD eyes, including both unilateral (AREDS IV) and bilateral (AREDS II)) over 3 years to specifically investigate the morphological sequence of events preceding the conversion towards late AMD. All patients will be followed by OCT …

55-90 years All Phase N/A
N Nam-Jong Paik, MD, PhD

Prognostic Value for Predicting Outcome Using Functional Near-infrared Spectroscopy in Stroke Rehabilitation

To investigate the prognostic value of Functional Near-Infrared Spectroscopy (fNIRS) in stroke rehabilitation with serial measurements.

18 years and older All Phase N/A
S Samuel Deshayes, MD

Biomarkers in Rheumatoid Arthritis Treated With Anti-interleukin-6 Therapy

The use of anti-interleukin (IL)-6 therapy, including tocilizumab, in rheumatoid arthritis or giant cell arteritis, led to the improvement or even control of disease in some patients for whom no further therapeutic options were available. Nevertheless, the evaluation of the efficacy of these treatments are negatively impacted by the lack …

18 years and older All Phase N/A

Simplify language using AI